news 2013

Scientists have discovered a new drug target for treating malaria. The discovery a novel experimental antimalarial compound class that inhibits the development of multiple malaria-causing Plasmodium species at each stage of infection in the human host. The on-going research to develop imidazopyrazines as a new treatment for malaria is supported by the Wellcome Trust and Medicines for Malaria Venture.

Next-generation drugs designed to fight Alzheimer's disease look very promising. Scientists have unveiled the mechanisms behind two classes of compound currently being tested in clinical trials. They have also identified a likely cause of early-onset hereditary forms of the disease. The future is looking good for drugs designed to combat Alzheimer's disease.